Roche (SIX: RO, ROG; OTCQX: RHHBY) shared real-world evidence from the rollout of Accu-Chek SmartGuide continuous glucose ...

"The SFDT1 study demonstrates that time spent in hypoglycaemic ranges alone is an inadequate predictor of severe events.

Here are four of the latest recalls and corrections reported to the FDA.

According to a new comprehensive report from The Insight Partners, the global connected health market is observing ...

Dexcom ( ($DXCM) ) has provided an announcement. On September 14, 2025, Dexcom announced that CEO and Chairman Kevin R. Sayer took a temporary ...

In financial filings, Casey Means stated that she would liquidate holdings in companies that sell personal devices, supplements, tobacco and tech.

Roche (RHHBY) said it shared real-world evidence from the rollout of Accu-Chek SmartGuide continuous glucose monitoring solution at the European ...

A new randomized controlled trial protocol from the Netherlands will test whether altering the texture, and thus the eating ...

2) The Oral Glucose Tolerance Test (OGTT) evaluates blood sugar levels two hours post-consumption of a 75 g glucose solution.

Superbet interviewed a series of professionals from the world of football to show the evolution of nutrition in ...